BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chauhan R, Lingala S, Gadiparthi C, Lahiri N, Mohanty SR, Wu J, Michalak TI, Satapathy SK. Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management. World J Hepatol 2018; 10(3): 352-370 [PMID: 29599899 DOI: 10.4254/wjh.v10.i3.352]
URL: https://www.wjgnet.com/1948-5182/full/v10/i3/352.htm
Number Citing Articles
1
Inmaculada Fernández, Juan Manuel Pascasio, Jordi Colmenero. Prophylaxis and treatment in liver transplantation. VII Consensus Document of the Spanish Society of Liver TransplantationGastroenterología y Hepatología (English Edition) 2020; 43(3): 169 doi: 10.1016/j.gastre.2019.11.001
2
A A Prasetyo, A T Permata, M Marwoto. Construction and molecular analysis of hepatitis B virus core 1-144 + human immunodeficiency virus Gag recombination from Indonesian isolatesIOP Conference Series: Materials Science and Engineering 2018; 434: 012113 doi: 10.1088/1757-899X/434/1/012113
3
Benoit Visseaux, Jérémie Gautier, Françoise Le Boulaire, Catherine Coignard, Claire Vincent, Sandrine Gréaume, Isabelle Voisin, Veronique Lemée, Jean-Christophe Plantier, Yves-Edouard Herpe, Etienne Brochot, Stephanie Bord, Marc Turini, Vanessa Roulet, Juliane Hey. Performance evaluation of the Access HBsAg and Access HBsAg confirmatory assays on the DxI 9000 Access Immunoassay AnalyzerPractical Laboratory Medicine 2024; 39: e00390 doi: 10.1016/j.plabm.2024.e00390
4
Yassmin Hegazy, Meagan Reif, Brenden M. McGuire, Robert Cannon, Babak Orandi, Mohamed Shoreibah. Liver Transplantation in Hepatitis B Reactivation in a Patient With Active HIV ViremiaACG Case Reports Journal 2022; 9(12): e00943 doi: 10.14309/crj.0000000000000943
5
Ilaria Lenci, Martina Milana, Giuseppe Grassi, Tommaso M Manzia, Carlo Gazia, Giuseppe Tisone, Roberta Angelico, Leonardo Baiocchi. Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger?World Journal of Gastroenterology 2020; 26(18): 2166-2176 doi: 10.3748/wjg.v26.i18.2166
6
Zahra Dossaji, Lubaba Haque, Adam Khattak, Mark Hsu, Robert Gish. A Review of Hepatitis B Reactivation Risk on Immunosuppressants with a Focus on Newer ImmunomodulatorsCurrent Hepatology Reports 2024;  doi: 10.1007/s11901-024-00662-7
7
Mariana Mihăilă, Cristina Mădălina Pascu, Andreea Andrunache, Cătălin Ștefan Ghenea. Antiviral Strategies in the Treatment of Human and Animal Viral InfectionsInfectious Diseases 2023; 27 doi: 10.5772/intechopen.112502
8
Ranjit Chauhan, Yoshimi Shimizu, Koichi Watashi, Takaji Wakita, Masayoshi Fukasawa, Tomasz I Michalak. Retrotransposon elements among initial sites of hepatitis B virus integration into human genome in the HepG2-NTCP cell infection modelCancer Genetics 2019; : 39 doi: 10.1016/j.cancergen.2019.04.060
9
Eva Maria Dobrindt, Eriselda Keshi, Yones Salim, Allan Gillespie, Akylbek Saipbaev, Wenzel Schöning, Robert Öllinger, Johann Pratschke, Dennis Eurich. Hepatitis B Immunoglobulin discontinuation in long‐term liver transplant patientsTransplant Infectious Disease 2020; 22(4) doi: 10.1111/tid.13303
10
Ümit ÖZÇELİK, Eryiğit EREN, Tutkun TALİH, Ömer ÖZOZAN, Fatih ENSAROĞLU. Karaciğer Nakli Sonrası Hepatit B Nüksünün Önlenmesinde Kısa Süreli Düşük Doz Hepatit B İmmünglobulini ile Nükleotid Analoğu Kombinasyonunun EtkinliğiBozok Tıp Dergisi 2020;  doi: 10.16919/bozoktip.661595
11
V. I. Reshetnyak, I. V. Maev, T. M. Reshetnyak, S. V. Zhuravel, V. M. Pisarev. Liver Diseases and the Hemostasis (Rewiew) Part 1. Non-Cholestatic Diseases of the Liver and HemostasisGeneral Reanimatology 2019; 15(5): 74 doi: 10.15360/1813-9779-2019-5-74-87
12
Masahiro Onozawa, Shigeru Kusumoto, Yuho Najima, Hiroya Hashimoto, Kohei Okada, Masaharu Tamaki, Masatsugu Tanaka, Takayuki Sato, Tsutomu Takahashi, Kaoru Hatano, Koichi Onodera, Yukiyoshi Moriuchi, Kimikazu Yakushijin, Junya Kanda, Koji Nagafuji, Masao Ogata, Nobuaki Nakano, Akihiro Tamori, Masashi Mizokami. Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective StudyTransplantation and Cellular Therapy 2024; 30(3): 330.e1 doi: 10.1016/j.jtct.2024.01.059
13
Ayfer Serin, Yaman Tokat. Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus–Related Chronic Liver DiseaseTransplantation Proceedings 2019; 51(7): 2457 doi: 10.1016/j.transproceed.2019.01.163
14
Xue‑Li Jin, Suk Hong, Hwajung Kim, Sun‑Kyung Lee, Nam‑Joon Yi, Kwang‑Woong Lee, Kyung‑Suk Suh. Antiviral therapy may decrease HBx, affecting cccDNA and MSL2 in hepatocarcinogenesisOncology Letters 2019;  doi: 10.3892/ol.2019.10833
15
Benjamine Khiangte, Sunil R. Kothakota, Madhu Sasidharan, Harish Kareem, Ajith K. Nair, Vijosh V. Kumar, Jagadeswara R. Kanala, Praveen C. Kumar. Hepatitis B Reactivation in Liver Transplant Recipients With Hepatitis B Virus Core Antibody Positive Grafts: a Retrospective StudyJournal of Clinical and Experimental Hepatology 2020; 10(6): 548 doi: 10.1016/j.jceh.2020.05.001
16
Xie Man, Rao Wei. Advancements in the prevention of hepatitis B recurrence by nucleos(t)ide analogue monotherapies after liver transplantationEuropean Journal of Inflammation 2022; 20: 1721727X2211392 doi: 10.1177/1721727X221139254
17
Fan Yu, Yuehua Huang, Yanying Wang, Zhuo Yu, Xinquan Li, Jiahong Dong. Very late onset post-transplant diffuse large B cell lymphoma in a liver transplant recipient with hepatitis BMedicine 2018; 97(44): e13063 doi: 10.1097/MD.0000000000013063
18
Adil Baskiran, Sami Akbulut, Tevfik Tolga Sahin, Cemalettin Koc, Serdar Karakas, Volkan Ince, Cihan Yurdaydin, Sezai Yilmaz. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantationHepatology International 2020; 14(5): 869 doi: 10.1007/s12072-020-10085-3
19
Haris Muhammad, Duha Zaffar, Aniqa Tehreem, Peng-Sheng Ting, Cem Simsek, Hale Gokcan, Ahmet Gurakar, Ramazan Idilman. HBV/HDV management after liver transplantation: ReviewJournal of Liver Transplantation 2021; 4: 100046 doi: 10.1016/j.liver.2021.100046
20
Bin Lou, Guanghua Ma, Feifei LV, Quan Yuan, Fanjie Xu, Yuejiao Dong, Sha Lin, Yajun Tan, Jie Zhang, Yu Chen. Baseline Quantitative Hepatitis B Core Antibody Titer Is a Predictor for Hepatitis B Virus Infection Recurrence After Orthotopic Liver TransplantationFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.710528
21
Inmaculada Fernández, Juan Manuel Pascasio, Jordi Colmenero, Carolina Almohalla Álvarez, Mª Carme Baliellas Comellas, Pilar Barrera Baena, Lluis Castells Fusté, Gonzalo Crespo Conde, Valentín Cuervas-Mons Martínez, Emilio Fábrega García, José Ramón Fernández Ramos, Miguel Juan García González, Luisa González Diéguez, José Ignacio Herrero Santos, Loreto Hierro Llanillo, Maria Isabel Monge Romero, Mª Flor Nogueras López, Esteban Otero Antón, Alejandra Otero Ferreiro, Elena Otón Nieto, Sonia Pascual Bartolomé, Maria Luisa Ortiz Sánchez, Martín Prieto Castillo, Mario Romero Cristóbal, Trinidad Serrano Aullo. Profilaxis y tratamiento de la infección por virus de la hepatitis B en el trasplante hepático. VII Documento de consenso de la Sociedad Española de Trasplante HepáticoGastroenterología y Hepatología 2020; 43(3): 169 doi: 10.1016/j.gastrohep.2019.11.005
22
Arun P. Nair, Sreethish Sasi, Muna S. Al‐Maslamani, Prem Chandra, Samar A. Hashim, Sulieman Abu Jarir, Moutaz Derbala. Epidemiological characteristics of de novo hepatitis B infection in liver transplant recipients—An experience from a tertiary care centre in QatarTransplant Infectious Disease 2020; 22(6) doi: 10.1111/tid.13444
23
Vanessa Meier-Stephenson, Maulik D. Badmalia, Tyler Mrozowich, Keith C.K. Lau, Sarah K. Schultz, Darren L. Gemmill, Carla Osiowy, Guido van Marle, Carla S. Coffin, Trushar R. Patel. Identification and characterization of a G-quadruplex structure in the pre-core promoter region of hepatitis B virus covalently closed circular DNAJournal of Biological Chemistry 2021; 296: 100589 doi: 10.1016/j.jbc.2021.100589
24
Felix Krenzien, Eriselda Keshi, Katrin Splith, Silvan Griesel, Kaan Kamali, Igor M. Sauer, Linda Feldbrügge, Johann Pratschke, Annekatrin Leder, Moritz Schmelzle. Diagnostic Biomarkers to Diagnose Acute Allograft Rejection After Liver Transplantation: Systematic Review and Meta-Analysis of Diagnostic Accuracy StudiesFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00758
25
Ramin Raul Ossami Saidy, Franziska Eurich, Maximilian Paul Postel, Eva Maria Dobrindt, Jasper Feldkamp, Selina Johanna Schaper, Johann Pratschke, Brigitta Globke, Dennis Eurich. Clinical and Histological Long-Term Follow-Up of De Novo HBV-Infection after Liver TransplantationMedicina 2021; 57(8): 767 doi: 10.3390/medicina57080767
26
Stela Celaj, Josh Levitsky. Prevention and Management of HBV in Organ TransplantationCurrent Hepatology Reports 2020; 19(3): 266 doi: 10.1007/s11901-020-00537-7
27
Ivana Lazarevic, Ana Banko, Danijela Miljanovic, Maja Cupic. Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic DilemmasViruses 2023; 15(2): 373 doi: 10.3390/v15020373
28
James S. Park, Vijay Gayam, Calvin Q. Pan. Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti‐viralsAlimentary Pharmacology & Therapeutics 2020; 52(6): 944 doi: 10.1111/apt.15999
29
Ramin Raul Ossami Saidy, Irina Sud, Franziska Eurich, Mustafa Aydin, Maximilian Paul Postel, Eva Maria Dobrindt, Johann Pratschke, Dennis Eurich. Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV InfectionViruses 2021; 13(5): 904 doi: 10.3390/v13050904
30
Ashwin Rammohan. Current management & future directions in post-liver transplant recurrence of viral hepatitisJournal of Liver Transplantation 2021; 3: 100027 doi: 10.1016/j.liver.2021.100027